This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2001 Feb 15;19(4):1226-8.

doi: 10.1200/JCO.2001.19.4.1226.

Adjuvant therapy of melanoma: at what cost?

PMID: 11181688
DOI: 10.1200/JCO.2001.19.4.1226

Comment

Adjuvant therapy of melanoma: at what cost?

L E Spitler. J Clin Oncol. 2001.

. 2001 Feb 15;19(4):1226-8.

doi: 10.1200/JCO.2001.19.4.1226.

Author

PMID: 11181688
DOI: 10.1200/JCO.2001.19.4.1226

No abstract available

PubMed Disclaimer

Comment on

Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: the Eastern Cooperative Oncology Group Trial EST 1684.
Kirkwood JM, Strawderman MH, Ernstoff MS, Smith TJ, Borden EC, Blum RH. Kirkwood JM, et al. J Clin Oncol. 1996 Jan;14(1):7-17. doi: 10.1200/JCO.1996.14.1.7. J Clin Oncol. 1996. PMID: 8558223 Clinical Trial.
High- and low-dose interferon alfa-2b in high-risk melanoma: first analysis of intergroup trial E1690/S9111/C9190.
Kirkwood JM, Ibrahim JG, Sondak VK, Richards J, Flaherty LE, Ernstoff MS, Smith TJ, Rao U, Steele M, Blum RH. Kirkwood JM, et al. J Clin Oncol. 2000 Jun;18(12):2444-58. doi: 10.1200/JCO.2000.18.12.2444. J Clin Oncol. 2000. PMID: 10856105 Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information